Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9573 posts found.

Merck image

Merck and Biocartis partner on new biomarker test for colorectal cancer

January 7, 2016 Research and Development BRAF mutations, Diagnostics, Erbitux, Merck, RAS metations, diagnostic tests, metastic colorectal cancer

Merck has signed a collaboration agreement with diagnostics company Biocartis for the development and commercialisation of a new test for …
News
Janssen image

Janssen, Enterome and Kymab in research collaborations

January 7, 2016 Research and Development Crohn's, Crohn’s disease, Enterome, Janssen, MD Anderson, alliance, antibodies, collaboration, crohn's disease, immuno-oncology, kymab, research

Several pharma companies have announced new collaborations, to research potential new drugs for Crohn’s disease, and immuno-oncology treatments for cancer. …
News
Gilead logo

Gilead terminates Phase II simtuzumab IPF study

January 6, 2016 Research and Development Gilead, IPF, idiopathic pulmonary fibrosis, simtuzumab

Gilead Sciences has announced the termination of its Phase II clinical study of the investigational monoclonal antibody simtuzumab in patients …
News
Exercise prostate cancer

Trial launched to test exercise as prostate cancer treatment

January 6, 2016 Research and Development Cancer Research UK, active surveillance, exercise, prostate cancer

Cancer Research UK has launched a study to determine if exercise could help men with prostate cancer, the UK’s most …
News
Alzheimer's brain

The case for adaptive trials in dementia

January 6, 2016 Manufacturing and Production, Research and Development Alzheimer's, Alzheimer's disease, adaptive trials, research

An ageing population and widespread chronic neuro-degenerative disease will make dementia an ever increasing burden on society, families and the …
Feature
NIHR logo

Roche teams with DH for drug repurposing trial

January 6, 2016 Research and Development DH, NIHR, Off Patent Drugs Bill, Off-Patent Drugs Bill, RoActemra, Roche, drug repurposing, tocilizumab

Roche and the UK Department of Health have launched a trial, to explore whether one of the company’s treatments for …
News
Enterome logo

Takeda and Enterome collaborate on new therapeutics for stomach disorders

January 6, 2016 Research and Development Enterome, Takeda, gastrointestinal, inflammatory bowel syndrome, irritable bowel syndrome

Takeda and Enterome Bioscience have entered a drug discovery collaboration to research and develop potential new therapeutics for disorders including …
News
Merck/MSD

MSD chooses partner to develop ‘game-changing’ cancer therapies

January 6, 2016 Research and Development CPABs, Cancer, Cell-Penetrating Alphabodies, Complix, MSD, autoimmune diseases

MSD has entered a research collaboration with biopharma company Complix, using the company’s proprietary technology to develop new treatments for …
News
afrezza_insulin

Sanofi abandons MannKind’s failed inhalable insulin

January 6, 2016 Manufacturing and Production, Research and Development, Sales and Marketing Afrezza, Mannkind, Sanofi, insulin

Sanofi is to exit a licensing and co-marketing deal with MannKind for the inhalable insulin Afrezza, after disappointing sales figures …
News
Gilead

Gilead success in late-stage hepatitis B trials

January 5, 2016 Research and Development, Sales and Marketing Gilead, hepatitis B, phase III

Two Phase III trials evaluating Gilead treatments in chronic hepatitis B virus (HBV) infection have met their primary objectives, showing …
News
Lilly building

Eli Lilly predicts revenue growth in 2016

January 5, 2016 Research and Development, Sales and Marketing Eli Lilly, financial reports, marketing, sales

Eli Lilly has set out its financial guidance for 2016, predicting an increase in sales to between $20.2 and $20.7 …
News
david_pyott

BioMarin elects former Allergan CEO to board

January 5, 2016 Medical Communications, Research and Development, Sales and Marketing

BioMarin Pharmaceutical has announced the election of former Allergan chief executive, David Pyott, to the company’s board of directors. Pyott served …
Appointment
Baxalta logo

Bayer and Baxalta in separate €1 billion-plus deals

January 5, 2016 Manufacturing and Production, Research and Development, Sales and Marketing Ascensia diabetes care, Baxalta, Bayer, diabetes, panasonic, symphogen

Baxalta has signed a deal with Symphogen potentially worth as much as €1.4 billion, under which the companies will develop …
News
Ovarian cancer

Pfizer, Merck and Syndax in ovarian cancer trial collaboration

January 5, 2016 Manufacturing and Production, Research and Development Merck, Pfizer, Syndax Pharmaceuticals, avelumab, entinostat, ovarian cancer

Pfizer, Merck and Syndax Pharmaceuticals have announced a collaboration to test avelumab, in combination with Syndax’s entinostat, in patients with …
News
AS spine fusion

Novartis’ Cosentyx shows benefits in Phase III AS trials

January 4, 2016 Research and Development, Sales and Marketing Cosentyx, Novartis, Secukinumab, ankylosing spondylitis

Novartis says results from two Phase III studies for Cosentyx in ankylosing spondylitis (AS) showing significant clinical improvements versus placebo.Results …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025